Science 2015
THE PRODUCT THAT YOU ARE LOOKING IS NOT AVAILABLE, WE RECOMMEND YOU:: - 500 70%,
To be considered for tirzepatide treatment, clients should meet the following requirements: A Body Mass Index (BMI) of 30 kg/m or higher, qualifying as obesity, or a BMI of 27 kg/m or higher if accompanied by at least one weight-related health condition, such as Type 2 diabetes, hypertension, dyslipidemia (high cholesterol or triglycerides), obstructive sleep apnea, or nonalcoholic fatty liver disease (NAFLD)
For this reason, it can be used in athletes and post-surgery patients
Furthermore, specific patient subgroups appear to derive particular advantages, including those with heart failure with preserved ejection fraction, chronic kidney disease, and high stroke risk